Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMEF2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,636
Award facts
- Contract value 100% obligated
- $57,636.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $57,636.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL autoinjector units. The contract carries an ultimate completion date of February 4, 2026, and was issued without set-aside designation, indicating the vendor's competitive standing in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to support recurring pharmaceutical supply needs across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group Inc. has been a registered federal contractor since 2001 and serves as a critical supplier within the military medical supply chain, distributing a comprehensive portfolio that includes branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support DoD operations globally. The vendor's established performance on multiple delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for military healthcare operations. No subcontractors are identified in this award, with the company serving as the sole performing contractor responsible for the delivery of the Xolair autoinjector units to the place of performance in Park Ridge, Illinois.
Quick answers
Who was awarded contract SPE2DR26FMEF2?
SPE2DR26FMEF2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FMEF2 worth?
The government has obligated $57,636 on SPE2DR26FMEF2.
Is contract SPE2DR26FMEF2 an order under another contract?
Yes. SPE2DR26FMEF2 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEF2 competed?
The extent of competition for SPE2DR26FMEF2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award